Ubs Global Asset Management Americas »

Rocket Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2025-09-30 $72k 22k 3.26
2025-06-30 $702k 286k 2.45
2025-03-31 $1.2M 185k 6.67
2024-12-31 $1.8M 140k 12.57
2024-09-30 $2.2M 120k 18.47
2024-06-30 $2.5M 118k 21.53
2024-03-31 $1.8M 66k 26.94
2023-12-31 $2.1M 71k 29.97
2023-09-30 $1.0M 50k 20.49
2023-06-30 $543k 32k 17.13
2023-03-31 $543k 32k 17.13
2022-12-31 $1.0M 54k 19.57
2022-09-30 $625k 39k 15.96
2022-06-30 $539k 39k 13.76
2022-03-31 $621k 39k 15.86
2021-12-31 $854k 39k 21.83
2021-09-30 $1.4M 48k 29.89
2021-06-30 $2.2M 49k 44.29
2021-03-31 $1.7M 37k 44.37
2020-12-31 $811k 36k 22.86
2020-09-30 $811k 36k 22.86
2020-06-30 $657k 31k 20.93
2019-12-31 $214k 9.4k 22.76
2019-06-30 $187k 12k 15.00